Polo-like kinase 2 is a mediator of hedgehog survival signaling in cholangiocarcinoma
Christian D. Fingas(Essen University Hospital), Gregory J. Gores(Mayo Clinic in Arizona), Svenja Sydor(Universitätsklinikum Knappschaftskrankenhaus Bochum), Alphonse E. Sirica(Virginia Commonwealth University), Nataliya Razumilava(University of Michigan), John D. Christensen(NOAA National Ocean Service), Joachim C. Mertens(GastroZentrum Hirslanden Zürich), Andreas Paul(Essen University Hospital), Ali Canbay(Universitätsklinikum Knappschaftskrankenhaus Bochum), Steven F. Bronk(Mayo Clinic), Jürgen Treckmann(Essen University Hospital)
Cited by 41
Related Papers
Hepatocellular carcinoma
|Nature Reviews Disease Primers|2016|2.7k
Cholangiocarcinoma 2020: the next horizon in mechanisms and management
|Nature Reviews Gastroenterology & Hepatology|2020|2.5k
Cholangiocarcinoma — evolving concepts and therapeutic strategies
|Nature Reviews Clinical Oncology|2017|1.7k
Design and Endpoints of Clinical Trials in Hepatocellular Carcinoma
|JNCI Journal of the National Cancer Institute|2008|1.7k
Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA)
|Nature Reviews Gastroenterology & Hepatology|2016|1.4k